LBF18107PG01

LipidBank Top (トップ)

Fatty acid (脂肪酸)

Glycerolipid (グリセロ脂質)

Sphingolipid (スフィンゴ脂質)

Journals (雑誌一覧)

How to edit (ページの書き方)

Upper classes: LB LBF

IDs and Links
LipidBank	XPR1821
LipidMaps	LMFA03010089
CAS
KEGG	{{{KEGG}}}
KNApSAcK	{{{KNApSAcK}}}
mol	LBF18107PG01

2,3-dinor-6-ketoprostaglandin F_1α
Structural Information
Systematic Name	5- [ 3 (R) ,5 (S) -Dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) cyclopentan-1 (R) -yl ] -4-oxopentanoic acid
Common Name	2,3-dinor-6-ketoprostaglandin F_1α 5- [ 3 (R) ,5 (S) -Dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) cyclopentan-1 (R) -yl ] -4-oxopentanoic acid
Symbol	2,3-DINOR-6-KETO-PGF1a
Formula	C18H30O6
Exact Mass	342.204238692
Average Mass	342.42719999999997
SMILES	[C@@H]([C@@H](CC(=O)CCC(O)=O)1)(C=C[C@H](O)CCCCC)[C@H](O)C[C@@H]1O
Physicochemical Information
Melting Point
Boiling Point
Density
Optical Rotation	[a]20.2D= +16.9° (C=1.76 CHLOROFORM, measured after 24 hours at 20°C)
Refractive Index
Solubility	METHANOL Pace-Asciak_CR et al.
Source	When prostaglandin I2 or its non-enzymatic degradation product (6-keto-prostaglandin F1a) was infused into man, a major urinary metbolite was 2,3-dinor-6-keto-prostaglandin F1a, a b-oxidation product Needleman_P et al..
Chemical Synthesis
Metabolism
Biological Activity
Genetic Information
Note
Spectral Information
Mass Spectra	METHOXIME TRI-TMS ETHER METHYL ESTER ; m/e 601(M+), 586, 570, 530, 511, 496, 480, 440, 421, 390, 350, 300, 294, 263, 217, 205, 191, 73 Pace-Asciak_CR et al.
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms

Reported Metabolites, References
Biospecies ID Compound Name Reference Comment n.a. LBF18107PG01 See above. Needleman_P et al. 1986 n.a. LBF18107PG01 See above. Pace-Asciak_CR et al. 1977